Contract Development And Manufacturing Organizations (CDMO)

A Whole New Range of New Services

Saltigo Offers Intelligent Custom Manufacturing

US Companies Point to Increased Federal Regulations as Barrier to Growth

SiVance Opens Lab for Silane and Silicone Technologies

Rottendorf Pharmaceuticals Signs Multiple New Deals

Aesica Secures Continuing FDA Approval of German Sites

Recipharm Delivers Complex Serialization Project for China

CPhI Worldwide Announces International Advisory Board

Camelot’s Pharma Management Radar

Vetter Announces Personnel Changes in its Development Service Division

Accelerating the Benefits Achievable from Biocatalysis

Consort Medical to Acquire Aesica Pharmaceuticals

Discovering the Future of Pharma

Almac Joins Academic and Industrial Partners to Find Green Chemicals

Mercachem to Acquire Synthon’s API Business

GDUFA’s Impact on the API Industry – an Update

ICIG is Looking to Expand its Two Major Platforms

Gallus BioPharmaceuticals appoints Claudette Kile as Vice President of Quality & Regulatory

SOCMA’s Annual Washington Fly-In

U.S. API Manufacturing and Sustainability

PCRAMS is a Booming Business

Standing Out in Global Pharmaceutical Contract Manufacturing Market

Outsourcing Biopharmaceutical Manufacturing

Double Risk with an Upgrade

Sourcing from India and China

Lonza’s Corporate Overhaul

Clariant to Sell Detergents & Intermediates Business to ICIG

Highly Potent API Demand is On the Rise

'A Unique Moment'

United in Philosophy and Approach

Saltigo: 'Working Proactively With Trends'

Adaptability — A lot has happened in the world of custom manufacturing since Saltigo was carved out of Lanxess' fine chemicals business in 2006.

Swiss Visionary

Enzymes as a Catalytic All Rounder

Monsanto Corn Failing To Protect Fields From Rootworms, Report Says

Saltigo to Provide Contract Manufacturing Services for Daiichi Sankyo

Saltigo has signed an agreement with Tokyo-based Daiichi Sankyo for the provision of contract manufacturing services; this comes ahead of Daiichi Sankyo's plans to commercialize one of its novel drug pipeline projects.